CHRNA7 and Parkinson disease: In a rat model of Parkinson’s disease (6-OHDA), oral administration of curcumin protected dopaminergic neurons in the substantia nigra and their terminals in the striatum through activation of the α7 nicotinic acetylcholine receptor (α7 nAChR), improving motor behavior [82,83].